HK Neopharm Limited is one of the most reliable manufacturers and suppliers of cagrilintide and semaglutide in China, featured by quality products and good price. Please rest assured to buy cagrilintide and semaglutide in stock here and get quotation from our factory. Customized orders are welcome.
Cagrilintide (CAS 1415456-99-3) is a long‑chain acylated amylin analogue and a dual agonist of amylin and calcitonin receptors. It shows significant advantages in obesity and type 2 diabetes management by suppressing appetite, delaying gastric emptying and stabilizing blood glucose. With long dosing intervals and reliable safety, Cagrilintide API provides a new target for metabolic drug development.
Technical Specifications
|
Product Name |
Cagrilintide |
|
Synonyms |
Cagrilintide API, Cagrilintide Powder |
|
Characteristics |
A white to off-white lyophilized powder |
|
CAS Number |
1415456-99-3 |
|
Assay |
≥99.0% (HPLC, Subject to the COA) |
|
Formula |
C194H312N54O59S2 |
|
Package |
Technical Package |
|
Storage |
Store in a tightly closed container, protected from light and moisture, at -20°C or below in a dry and ventilated environment. Avoid repeated freeze-thaw cycles. For long-term storage, maintain under inert gas protection to ensure product stability and purity. |
|
Structure |
|
This product is often used in combination with semaglutide, and their complementary mechanisms deliver synergistic weight‑loss and hypoglycemic effects. Clinical studies prove the combination superior to monotherapy in improving body weight and metabolic markers. As high‑purity Cagrilintide Powder, it is a core raw material for compound metabolic drug development.
Product Characteristics
Cagrilintide (CAS 1415456-99-3) is a white to off‑white powder, a highly potent long‑acting amylin analogue that regulates appetite and gastric emptying, performing well in weight and glucose control.
It features excellent structural stability, long half‑life, low dosing frequency and good tolerability, providing stable support for the development of anti‑obesity and anti‑diabetic drugs.
Cagrilintide can be used with semaglutide cagrilintide for synergistic effects, offering superior outcomes over single agents and great value for novel compound drug R&D.
Produced under strict quality control, the product has high purity, low impurities and consistent batch performance, ideal for R&D and large‑scale production of innovative metabolic therapies.
Full-Cycle Quality Control and Stable Quality
In innovative metabolic drug development, API quality determines safety and efficacy. The combined system of cagrilintide and semaglutide is managed under a full standardized quality system to ensure stable performance for drug R&D.
From raw material input to final inspection, we implement closed‑loop quality control to ensure purity, activity and impurity profiles meet high industry standards, maintaining stable quality of cagrilintide and semaglutide.
Mature production and fine process control ensure high batch consistency, stable physicochemical properties and reliable performance, reducing risks for long‑term compound drug development.
Continuous traceability and process optimization strengthen our quality system. As a trusted China Cagrilintide manufacturer, we supply stable and consistent materials for global R&D and industrialization.
Application Scenarios
Used alone, Cagrilintide acts on amylin and calcitonin receptors, suitable for research on simple obesity and metabolic syndrome as a reliable API source.
Semaglutide cagrilintide is widely used in type 2 diabetes and obesity R&D, supporting formulation development, preclinical evaluation and scaled production.
Their combined formulation delivers enhanced weight reduction and glycemic control, addressing high unmet needs in severe obesity and refractory hyperglycemia.
With stable quality, the product serves pharmaceutical companies and research institutes, supporting lab trials, pilot scale‑up and industrial production for innovative metabolic treatments.
Cagrilintide and semaglutide can be used separately or in combination, covering a wide range of applications in metabolic disorders, offering flexible solutions for clinical research and new drug development.
Packaging and Transportation
We build a pharmaceutical‑grade protection system for packaging and logistics, using scientific design and reliable transport to ensure safe, efficient delivery.
Products are packaged in light‑proof sealed containers with inert gas protection, moisture and shock resistance to preserve stability from factory to use.
Transport is carried out under strict temperature and vibration control to maintain product integrity in long‑haul and cross‑border delivery.
Flexible packaging sizes with clear labeling meet various order volumes. A fully traceable logistics system ensures secure and efficient supply service.
Our Advantages
We produce Cagrilintide and semaglutide separately and support compound formulation development, offering one‑stop supply for diverse R&D projects.
Advanced peptide synthesis and purification ensure high purity, controlled impurities and excellent batch consistency for reliable R&D data.
A full‑cycle quality control system guarantees stable high‑quality output, supporting the development of safe and effective metabolic drugs.
Large‑scale production capacity enables fast response for small, pilot and industrial orders with on‑time delivery.
Our professional technical team provides targeted support for monotherapy and combination use, maximizing cooperation value.
FAQ
We focus on high‑standard peptide APIs, supplying premium Cagrilintide and semaglutide for monotherapy and combination use. Supported by full‑cycle QC, stable capacity and professional service, we accelerate metabolic drug development. As a reliable China Cagrilintide supplier, we welcome global partnerships to advance innovative therapies.
Hot Tags: cagrilintide and semaglutide, China cagrilintide and semaglutide manufacturers, suppliers, factory
